China pharma announces receipt of notification of nyse american listing deficiency

Haikou, china , oct. 1, 2022 /prnewswire/ -- china pharma holdings, inc. (nyse american: cphi; the "company") today announced that on september 26, 2022, the company received notification (the "deficiency letter") from the nyse american llc ("nyse american") informing it that the company is not in compliance with certain nyse american continued listing standards (the "listing standards"). the deficiency letter indicated that the company's securities had been selling for a low price per share for a substantial period of time and, most recently, the average price of the company's common stock had been below $0.20 on a 30-day average as of september 22, 2022.
CPHI Ratings Summary
CPHI Quant Ranking